Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema

Clinical trial NCT04543331 · COMPLETED

Trial details

NCT number: NCT04543331
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Neovascular Age-related Macular Degeneration (nAMD)Diabetic Macular Edema (DME)

Start date: 2020-11-05
Primary completion: 2025-11-17
Enrollment: 572

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.